Concepedia

A. Hontsa

AH

Statistics

Publications

3

Citations

260

H-Index

3

Active since

2014

Affiliations

Yuriy Fedkovych Chernivtsi National University(Current)

Dnipro State Medical University

A. Hontsa is an author at Yuriy Fedkovych Chernivtsi National University specializing in chemotherapy, oncology, and medicine.

Publications per year

2014–2020

3

Publications

3

A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy

Richard J. Gralla, Snežana Bošnjak, A. Hontsa et al. · Annals of Oncology · 2014 · 190 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer

Jaffer A. Ajani, Mikhail Abramov, Igor Bondarenko et al. · Annals of Oncology · 2017 · 45 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

A phase III, randomized, double-blind, multicenter study to compare the efficacy, safety, pharmacokinetics, and immunogenicity between SB8 (proposed bevacizumab biosimilar) and reference bevacizumab in patients with metastatic or recurrent nonsquamous non-small cell lung cancer

Martin Reck, Alexander Luft, Igor Bondarenko et al. · Lung Cancer · 2020 · 25 citations · Full text

Pharmacy, Oncology, Pharmacokinetics +11

1–3 of 3